Lead
"The fever is down, so I stopped the antibiotics." For streptococcal pharyngitis, that decision can have long-term consequences.
Pharyngitis caused by Group A beta-hemolytic streptococcus (GAS) is most common in children aged 5–15, with typical features of high fever, severe sore throat, redness and exudate: pus or fluid oozing from inflamed tissue, here visible on the tonsils on the tonsils. Transmission is through droplets and direct contact; household transmission rates are approximately 25% [1]. Diagnosis relies on rapid antigen testing (sensitivity 80–90%, specificity 95–99%) [2], but if clinical suspicion is high despite a negative test, throat culture is recommended to confirm [1]. Distinguishing GAS pharyngitis from viral pharyngitis at home is not possible; the diagnosis belongs with a clinician.
Completing the antibiotic course has an evidence-based rationale that is separate from the goal of resolving symptoms — and it concerns what can happen to the body after fever disappears.
The Core Reason for Completing the Course: Preventing Acute Rheumatic Fever
Acute rheumatic fever (ARF) is a late complication of GAS pharyngitis in which an inappropriate immune response causes damage to the heart, joints, and nervous system. The leading hypothesis for the mechanism is "molecular mimicry: when immune responses to a pathogen accidentally attack the body's own tissues because of structural similarity" — surface proteins on GAS structurally resemble proteins in heart muscle, so the immune response targeting the bacteria also attacks the heart's own tissue [3]. Repeated episodes of ARF can progress to valvular disease: damage to the heart valves that impairs their ability to open or close properly (rheumatic heart disease).
ARF incidence in high-income countries is approximately 0.3% of all GAS pharyngitis cases, but in low- and middle-income countries it reaches up to 3%, making it a significant global disease burden [3]. Evidence that a 10-day course of penicillin or amoxicillin prevents ARF has been accumulating since controlled trials in the 1950s [4]. A 2009 scientific statement from the American Heart Association (AHA) identifies this regimen as the first-line treatment and reports ARF prevention efficacy of 80–90% [1].
Macrolides: a class of antibiotics including clarithromycin and azithromycin that inhibit bacterial protein synthesis (clarithromycin and similar) are an alternative with 5-day course options, but in Japan GAS macrolide resistance rates are reported at approximately 60–80% [5,6]. Confirming the type of antibiotic prescribed and the prescribed duration is therefore important — the relevant variable is not "antibiotics were prescribed" but "the right antibiotic for the full prescribed duration."
What Antibiotics Cannot Prevent, and When to Return to School
One point worth being precise about. There is another GAS-associated late complication — post-streptococcal glomerulonephritis (PSGN) — and antibiotics do not prevent it [1]. PSGN develops when immune complexes: clusters of antibodies bound to antigens that can lodge in tissues and trigger inflammation form and deposit in the kidneys after infection with certain GAS strains; whether it occurs is determined by which strain caused the infection, not by whether treatment was adequate. The purpose of completing the antibiotic course is ARF prevention. Kidney complications are a separate matter.
This distinction is worth knowing: if PSGN develops despite completed treatment, that is not a treatment failure. If urine turns red-brown or swelling develops within 2–3 weeks after a GAS infection, a prompt call to the child's doctor is warranted.
For return to school, the general guideline is that a child may return after being on antibiotics for at least 24 hours and being afebrile [1]. If a sibling develops sore throat symptoms around the same time, scheduling a same-day appointment for both is a reasonable option, given the approximately 25% household transmission rate [1].
Managing the Course at Home
Ten days is the medically grounded duration for the reasons above — but once fever has resolved, it is common for children to resist taking medication. A few straightforward strategies:
- Visualize the remaining days ("three more days after today") rather than just telling a child to keep going
- If a dose is missed, take it as soon as it is remembered the same day (do not double up the next dose)
- Keep a note of the start date and the day the course should end — especially if managing two or more children's courses simultaneously
Writing down the prescription start date and the expected end date somewhere easy to find makes follow-up visits and managing sibling cases much more straightforward.
Summary
The 10-day antibiotic course for strep throat is not a precaution or a formality. It is an action with specific evidence behind it — the prevention of acute rheumatic fever, a heart complication, that can follow inadequately treated GAS infection. Resolution of fever is not the same as the completion of treatment. This is one of the few infections for which that is the explicit point.
Diagnosis confirmed, course completed. That simple sequence, followed consistently, connects to long-term heart health.
References
- Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association. Circulation. 2009;119(11):1541–1551. doi:10.1161/CIRCULATIONAHA.109.191959. PMID: 19246689.
- Tanz RR, Gerber MA, Kabat W, Rippe J, Seshadri R, Shulman ST. Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics. 2009;123(2):437–444. doi:10.1542/peds.2008-0488. PMID: 19171607.
- Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–694. doi:10.1016/S1473-3099(05)70267-X. PMID: 16253886.
- Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10(6):673–695. doi:10.1016/0002-9343(51)90159-0. PMID: 14824268.
- Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86–102. doi:10.1093/cid/cis629. PMID: 22965026.
- Japanese Society of Infectious Diseases / Japanese Society of Chemotherapy. Clinical Practice Guideline for Group A Beta-Hemolytic Streptococcal Pharyngitis. 2020 edition.